Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1408 | Thyroid (non-cancer) | ECE2017

Evaluation of disease outcome in patients affected with differentiated thyroid carcinoma treated with total thyroidectomy or lobectomy

Colombo Carla , De Leo Simone , Perrino Michela , Di Stefano Marta , Cantoni Gianmaria , Vicentini Leonardo , Fugazzola Laura

Abstract: An individualized risk-based approach to the treatment of thyroid cancer is being extensively discussed in the recent literature, but controversies remain about the ideal surgical approach. In particular, if some data showed that properly selected thyroid cancer patients can be treated with lobectomy (LT) with excellent clinical outcomes, other results demonstrated an increased incidence of persistent recurrent disease in patients submitted to LT with respect to thos...

ea0070aep881 | Thyroid | ECE2020

The diagnostic value of basal and calcium-stimulated procalcitonin for the diagnosis of medullary thyroid cancer: Preliminary results from a multicentric experience

Censi Simona , Di Stefano Marta , Repaci Andrea , Manso Jacopo , Pagotto Uberto , Bertazza Loris , Barollo Susi , Plebani Mario , Colombo Carla , Fugazzola Laura , Mian Caterina

Background: Calcitonin (CT) is the most sensitive marker for MTC diagnosis. By the way, many pre-analytical, analytical and post-analytical pitfalls worsen its accuracy. Procalcitonin (proCT), a CT precursor, has been suggested as a valuable complementary test in MTC diagnosis, given its stability and the reproducibility between different assay kits.Material and Methods: basal CT (bCT) and proCT (bproCT) and stimulated CT (bCT) and proCT (sproCT) (2&#821...